These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12888358)

  • 1. Assessing the evidence for organised cancer screening programmes.
    Madlensky L; Goel V; Polzer J; Ashbury FD
    Eur J Cancer; 2003 Aug; 39(12):1648-53. PubMed ID: 12888358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Organised' cervical screening 45 years on: How consistent are organised screening practices?
    Williams JH; Carter SM; Rychetnik L
    Eur J Cancer; 2014 Nov; 50(17):3029-38. PubMed ID: 25282406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Register-based studies of cancer screening effects.
    Von Euler-Chelpin M; Lynge E; Rebolj M
    Scand J Public Health; 2011 Jul; 39(7 Suppl):158-64. PubMed ID: 21775376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in Italy.
    Segnan N; Ronco G; Ciatto S
    Eur J Cancer; 2000 Nov; 36(17):2235-9. PubMed ID: 11072211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of randomised controlled trials examining the effectiveness of breast and cervical cancer screening interventions for ethnic minority women.
    Chan DN; So WK
    Eur J Oncol Nurs; 2015 Oct; 19(5):536-53. PubMed ID: 25840817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of organised versus opportunistic mammography screening.
    Bulliard JL; Ducros C; Jemelin C; Arzel B; Fioretta G; Levi F
    Ann Oncol; 2009 Jul; 20(7):1199-202. PubMed ID: 19282467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in Greece.
    Riza E; Kyriakogianni-Psaropoulou P; Koumantakis E; Symiakaki H; Garas I; Linos A
    Eur J Cancer; 2000 Nov; 36(17):2227-32. PubMed ID: 11072209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):37-54. PubMed ID: 18770994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer (over-)screening in Europe: Balancing organised and opportunistic programmes.
    De Prez V; Jolidon V; Cullati S; Burton-Jeangros C; Bracke P
    Scand J Public Health; 2023 Dec; 51(8):1239-1247. PubMed ID: 36016469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):659-64. PubMed ID: 3092971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.
    Lăără E; Day NE; Hakama M
    Lancet; 1987 May; 1(8544):1247-9. PubMed ID: 2884378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction. The diffusion of screening programmes in Italy: 2008.
    Zappa M; Grazzini G; Naldoni C; Paci E; Segnan N; Federici A
    Epidemiol Prev; 2010; 34(5-6 Suppl 4):5-8. PubMed ID: 21220833
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative technologies in cervical cancer screening: a randomised evaluation trial.
    Anttila A; Hakama M; Kotaniemi-Talonen L; Nieminen P
    BMC Public Health; 2006 Oct; 6():252. PubMed ID: 17042938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.